pUC57-CD19(human)-P2A-EGFP

$84.00
In stock
SKU
PL37481

NM_001178098.2;B4; CVID3

100μg liquid plasmid(Instantly):$105

 name  pUC57-CD19(human)-P2A-EGFP another name apUC57-CD19(human)-P2A-EGFP
Insert Size (bp) 1671bp Plasmid host Escherichia coli
Plasmid uses Gene template Fragment type cDNA
Fragment species  Human Prokaryotic resistance Amp
Selective marker Fluorescent labeling
Promoter Replicon pUC
Competence DH5a Growth Temperature 37°C
Vector backbone 5′ sequencing primer
3′ sequencing primer Copy number
Induction methodanother name    

 

1. All products on this platform are only for scientific research and cannot be used for clinical trials;
2. The small package of plasmids is sold at the price of the template, which only guarantees the correct sequencing of the gene part, and does not guarantee the experimental effect such as the expression of the plasmid;
3. Some plasmids have not been completely sequenced even if they are produced by the company, and if the sequence sequencing of key parts is correct, it is also considered to be the correct plasmid;
4. The after-sales period of small package plasmid products is 3 months from the date you receive the product.
5. Plasmid construction is charged at cost, all plasmids will be shared with other experimenters, please inform and pay confidential fees in advance for confidential plasmids;
6. Because scientific research is an activity to explore the unknown, there is great uncertainty, so Biogege does not bear additional joint and several liability under any circumstances;
7. Publication [Chinese papers] please mark: product name (product item number) provided by Biogege;
8. Please mark Product Name (Product Item Number) was obtained from Biogege,China.

 

 

Instructions

Plasmid dry powder (stored at minus 20 degrees, shelf life 90 days, transportation at room temperature)
1. After receiving the dry powder plasmid, please centrifuge at 5000rpm for 1min, and then add 20μl of sterile water to dissolve the plasmid;
2. Thaw the corresponding competent on an ice box, take 2 μl of plasmid and add it to 100 μl of competent for 30min;
3. 42 degrees heat shock for 60s, ice bath for 2min, add 900 of antibiotic-free LB medium, and culture at 180rpm shaking for 45min;
4. Centrifuge at 6000rpm for 3min, leave 100μl of supernatant to resuspend, and then coat it on the corresponding resistant LB plate;
5.After inverting overnight, if there are too many colonies, the plasmid will be diluted for transformation, and if there are no colonies, 10ul plasmid will be taken for transformation;
6. Pick single colonies into the corresponding resistant LB liquid medium overnight shaking culture, and extract the plasmid as needed.

Liquid plasmid (minus 20 degrees storage, shelf life 90 days, ice pack transportation).
1. After receiving the liquid plasmid, please shake the preservation tube so that the liquid plasmid does not adsorb on the tube wall;
2.Take an appropriate amount of plasmid according to the experimental needs, and store the rest in a minus 20 degree freezer.

Glycerol strains (stored at minus 80 degrees, shelf life of 90 days, ice pack transportation).
1. After receiving the glycerol strain, please shake the preservation tube so that the bacterial solution does not adsorb on the tube wall;
2. Use the inoculation loop to mark the line in four areas on the solid plate, and add the corresponding resistance if there is resistance;
3. Inverted culture in constant temperature incubator for 12~16h;
4. Be sure to pick a single colony and inoculate it in the liquid medium, and add the corresponding resistance if there is resistance;
5. Shake the shaker and culture overnight, and culture the strains according to the needs of the experiment.

TCGCGCGTTT CGGTGATGAC GGTGAAAACC TCTGACACAT GCAGCTCCCG GAGACGGTCA CAGCTTGTCT GTAAGCGGAT GCCGGGAGCA GACAAGCCCG TCAGGGCGCG TCAGCGGGTG TTGGCGGGTG TCGGGGCTGG CTTAACTATG CGGCATCAGA GCAGATTGTA CTGAGAGTGC ACCATATGCG GTGTGAAATA CCGCACAGAT GCGTAAGGAG AAAATACCGC ATCAGGCGCC ATTCGCCATT CAGGCTGCGC AACTGTTGGG AAGGGCGATC GGTGCGGGCC TCTTCGCTAT TACGCCAGCT GGCGAAAGGG GGATGTGCTG CAAGGCGATT AAGTTGGGTA ACGCCAGGGT TTTCCCAGTC ACGACGTTGT AAAACGACGG CCAGTGAATT CTAATACGAC TCACTATAGG GGCAAAAATC AAAATCAATC ATCATCACAA CATCAACAAT CAATCATCAA CACATCATCA AGACACCACC TCTAGAGCCA CCATGCCACC TCCTCGCCTC CTCTTCTTCC TCCTCTTCCT CACCCCCATG GAAGTCAGGC CCGAGGAACC TCTAGTGGTG AAGGTGGAAG AGGGAGATAA CGCTGTGCTG CAGTGCCTCA AGGGGACCTC AGATGGCCCC ACTCAGCAGC TGACCTGGTC TCGGGAGTCC CCGCTTAAAC CCTTCTTAAA ACTCAGCCTG GGGCTGCCAG GCCTGGGAAT CCACATGAGG CCCCTGGCCA TCTGGCTTTT CATCTTCAAC GTCTCTCAAC AGATGGGGGG CTTCTACCTG TGCCAGCCGG GGCCCCCCTC TGAGAAGGCC TGGCAGCCTG GCTGGACAGT CAATGTGGAG GGCAGCGGGG AGCTGTTCCG GTGGAATGTT TCGGACCTAG GTGGCCTGGG CTGTGGCCTG AAGAACAGGT CCTCAGAGGG CCCCAGCTCC CCTTCCGGGA AGCTCATGAG CCCCAAGCTG TATGTGTGGG CCAAAGACCG CCCTGAGATC TGGGAGGGAG AGCCTCCGTG TCTCCCACCG AGGGACAGCC TGAACCAGAG CCTCAGCCAG GACCTCACCA TGGCCCCTGG CTCCACACTC TGGCTGTCCT GTGGGGTACC CCCTGACTCT GTGTCCAGGG GCCCCCTCTC CTGGACCCAT GTGCACCCCA AGGGGCCTAA GTCATTGCTG AGCCTAGAGC TGAAGGACGA TCGCCCGGCC AGAGATATGT GGGTAATGGA GACGGGTCTG TTGTTGCCCC GGGCCACAGC TCAAGACGCT GGAAAGTATT ATTGTCACCG TGGCAACCTG ACCATGTCAT TCCACCTGGA GATCACTGCT CGGCCAGTAC TATGGCACTG GCTGCTGAGG ACTGGTGGCT GGAAGGTCTC AGCTGTGACT TTGGCTTATC TGATCTTCTG CCTGTGTTCC CTTGTGGGCA TTCTTCATCT TCAAAGAGCC CTGGTCCTGA GGAGGAAAAG AAAGCGAATG ACTGACCCCA CCAGGAGATT CTTCAAAGTG ACGCCTCCCC CAGGAAGCGG GCCCCAGAAC CAGTACGGGA ACGTGCTGTC TCTCCCCACA CCCACCTCAG GCCTCGGACG CGCCCAGCGT TGGGCCGCAG GCCTGGGGGG CACTGCCCCG TCTTATGGAA ACCCGAGCAG CGACGTCCAG GCGGATGGAG CCTTGGGGTC CCGGAGCCCG CCGGGAGTGG GCCCAGAAGA AGAGGAAGGG GAGGGCTATG AGGAACCTGA CAGTGAGGAG GACTCCGAGT TCTATGAGAA CGACTCCAAC CTTGGGCAGG ACCAGCTCTC CCAGGATGGC AGCGGCTACG AGAACCCTGA GGATGAGCCC CTGGGTCCTG AGGATGAAGA CTCCTTCTCC AACGCTGAGT CTTATGAGAA CGAGGATGAA GAGCTGACCC AGCCGGTCGC CAGGACAATG GACTTCCTGA GCCCTCATGG GTCAGCCTGG GACCCCAGCC GGGAAGCAAC CTCCCTGGCA GGGTCCCAGT CCTATGAGGA TATGAGAGGA ATCCTGTATG CAGCCCCCCA GCTCCGCTCC ATTCGGGGCC AGCCTGGACC CAATCATGAG GAAGATGCAG ACTCTTATGA GAACATGGAT AATCCCGATG GGCCAGACCC AGCCTGGGGA GGAGGGGGCC GCATGGGCAC CTGGAGCACC AGGTCTAGAG CAACAAACTT CTCTCTGCTG AAACAAGCCG GAGATGTCGA AGAGAATCCT GGACCGGCCA CCATGGTGAG CAAGGGCGAG GAGCTGTTCA CCGGGGTGGT GCCCATCCTG GTCGAGCTGG ACGGCGACGT AAACGGCCAC AAGTTCAGCG TGTCCGGCGA GGGCGAGGGC GATGCCACCT ACGGCAAGCT GACCCTGAAG TTCATCTGCA CCACCGGCAA GCTGCCCGTG CCCTGGCCCA CCCTCGTGAC CACCCTGACC TACGGCGTGC AGTGCTTCAG CCGCTACCCC GACCACATGA AGCAGCACGA CTTCTTCAAG TCCGCCATGC CCGAAGGCTA CGTCCAGGAG CGCACCATCT TCTTCAAGGA CGACGGCAAC TACAAGACCC GCGCCGAGGT GAAGTTCGAG GGCGACACCC TGGTGAACCG CATCGAGCTG AAGGGCATCG ACTTCAAGGA GGACGGCAAC ATCCTGGGGC ACAAGCTGGA GTACAACTAC AACAGCCACA ACGTCTATAT CATGGCCGAC AAGCAGAAGA ACGGCATCAA GGTGAACTTC AAGATCCGCC ACAACATCGA GGACGGCAGC GTGCAGCTCG CCGACCACTA CCAGCAGAAC ACCCCCATCG GCGACGGCCC CGTGCTGCTG CCCGACAACC ACTACCTGAG CACCCAGTCC GCCCTGAGCA AAGACCCCAA CGAGAAGCGC GATCACATGG TCCTGCTGGA GTTCGTGACC GCCGCCGGGA TCACTCTCGG CATGGACGAG CTGTACAAGT GACCACACCC CCACGGGAAA CAGCAGTGAT TAACCTTTAG CAATAAACGA AAGTTTAACT AAGCTATACT AACCCCAGGG TTGGTCAATT TCGTGCCAGC CACACCGGAT CCCGGGCCCG TCGACTGCAG AGGCCTGCAT GCAAGCTTGG CGTAATCATG GTCATAGCTG TTTCCTGTGT GAAATTGTTA TCCGCTCACA ATTCCACACA ACATACGAGC CGGAAGCATA AAGTGTAAAG CCTGGGGTGC CTAATGAGTG AGCTAACTCA CATTAATTGC GTTGCGCTCA CTGCCCGCTT TCCAGTCGGG AAACCTGTCG TGCCAGCTGC ATTAATGAAT CGGCCAACGC GCGGGGAGAG GCGGTTTGCG TATTGGGCGC TCTTCCGCTT CCTCGCTCAC TGACTCGCTG CGCTCGGTCG TTCGGCTGCG GCGAGCGGTA TCAGCTCACT CAAAGGCGGT AATACGGTTA TCCACAGAAT CAGGGGATAA CGCAGGAAAG AACATGTGAG CAAAAGGCCA GCAAAAGGCC AGGAACCGTA AAAAGGCCGC GTTGCTGGCG TTTTTCCATA GGCTCCGCCC CCCTGACGAG CATCACAAAA ATCGACGCTC AAGTCAGAGG TGGCGAAACC CGACAGGACT ATAAAGATAC CAGGCGTTTC CCCCTGGAAG CTCCCTCGTG CGCTCTCCTG TTCCGACCCT GCCGCTTACC GGATACCTGT CCGCCTTTCT CCCTTCGGGA AGCGTGGCGC TTTCTCATAG CTCACGCTGT AGGTATCTCA GTTCGGTGTA GGTCGTTCGC TCCAAGCTGG GCTGTGTGCA CGAACCCCCC GTTCAGCCCG ACCGCTGCGC CTTATCCGGT AACTATCGTC TTGAGTCCAA CCCGGTAAGA CACGACTTAT CGCCACTGGC AGCAGCCACT GGTAACAGGA TTAGCAGAGC GAGGTATGTA GGCGGTGCTA CAGAGTTCTT GAAGTGGTGG CCTAACTACG GCTACACTAG AAGAACAGTA TTTGGTATCT GCGCTCTGCT GAAGCCAGTT ACCTTCGGAA AAAGAGTTGG TAGCTCTTGA TCCGGCAAAC AAACCACCGC TGGTAGCGGT GGTTTTTTTG TTTGCAAGCA GCAGATTACG CGCAGAAAAA AAGGATCTCA AGAAGATCCT TTGATCTTTT CTACGGGGTC TGACGCTCAG TGGAACGAAA ACTCACGTTA AGGGATTTTG GTCATGAGAT TATCAAAAAG GATCTTCACC TAGATCCTTT TAAATTAAAA ATGAAGTTTT AAATCAATCT AAAGTATATA TGAGTAAACT TGGTCTGACA GTTACCAATG CTTAATCAGT GAGGCACCTA TCTCAGCGAT CTGTCTATTT CGTTCATCCA TAGTTGCCTG ACTCCCCGTC GTGTAGATAA CTACGATACG GGAGGGCTTA CCATCTGGCC CCAGTGCTGC AATGATACCG CGAGACCCAC GCTCACCGGC TCCAGATTTA TCAGCAATAA ACCAGCCAGC CGGAAGGGCC GAGCGCAGAA GTGGTCCTGC AACTTTATCC GCCTCCATCC AGTCTATTAA TTGTTGCCGG GAAGCTAGAG TAAGTAGTTC GCCAGTTAAT AGTTTGCGCA ACGTTGTTGC CATTGCTACA GGCATCGTGG TGTCACGCTC GTCGTTTGGT ATGGCTTCAT TCAGCTCCGG TTCCCAACGA TCAAGGCGAG TTACATGATC CCCCATGTTG TGCAAAAAAG CGGTTAGCTC CTTCGGTCCT CCGATCGTTG TCAGAAGTAA GTTGGCCGCA GTGTTATCAC TCATGGTTAT GGCAGCACTG CATAATTCTC TTACTGTCAT GCCATCCGTA AGATGCTTTT CTGTGACTGG TGAGTACTCA ACCAAGTCAT TCTGAGAATA GTGTATGCGG CGACCGAGTT GCTCTTGCCC GGCGTCAATA CGGGATAATA CCGCGCCACA TAGCAGAACT TTAAAAGTGC TCATCATTGG AAAACGTTCT TCGGGGCGAA AACTCTCAAG GATCTTACCG CTGTTGAGAT CCAGTTCGAT GTAACCCACT CGTGCACCCA ACTGATCTTC AGCATCTTTT ACTTTCACCA GCGTTTCTGG GTGAGCAAAA ACAGGAAGGC AAAATGCCGC AAAAAAGGGA ATAAGGGCGA CACGGAAATG TTGAATACTC ATACTCTTCC TTTTTCAATA TTATTGAAGC ATTTATCAGG GTTATTGTCT CATGAGCGGA TACATATTTG AATGTATTTA GAAAAATAAA CAAATAGGGG TTCCGCGCAC ATTTCCCCGA AAAGTGCCAC CTGACGTCTA AGAAACCATT ATTATCATGA CATTAACCTA TAAAAATAGG CGTATCACGA GGCCCTTTCG TC

Reviews

Write Your Own Review
You're reviewing:pUC57-CD19(human)-P2A-EGFP
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.